News
AlTi Global, Inc. (NASDAQ:ALTI) Q2 2023 Earnings Conference Call August 15, 2023 5:00 PM ET Company Participants Lily Arteaga – Head of Investor Relations...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
Operator Greetings, and welcome to Ark Restaurants Fourth Quarter and Year-End 2025 Results Call. [Operator Instructions]. As a reminder, this conference is being recorded....
News
This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector with years of experience utilizing his Applied Science...
News
A company of Manulife Investment Management, John Hancock Investment Management serves investors through a unique multimanager approach, complementing our extensive in-house capabilities with an...
News
Samsonite International S.A. (OTCPK:SMSOF) Q2 2023 Earnings Conference Call August 16, 2023 9:00 PM ET Company Participants William Yue – Investor Relations Kyle Gendreau...
News
The Shopify Investment Thesis Appears Bright, Thanks To The Two Pronged Approach We previously covered Shopify (NYSE:SHOP) in May 2023, discussing the management’s decision...
News
Dear Fellow Shareholders, FPA New Income Fund (MUTF:FPNIX, the “Fund”) returned 0.21% in the second quarter of 2023 and 2.24% year-to- date through June...
News
Dear Shareholder Performance Overview The FPA Crescent Fund – Institutional Class (MUTF:FPCSX, “Fund” or “Crescent”) gained 6.29% in Q2 2023 and 16.13% in the...
News
In this series of articles, we focus on selecting and highlighting stocks that have been growing their dividends in the recent past at a...
News
Seeks Growth & Capital Preservation (Performance (%) as of 6-30-2023) QTR YTD 1 Yr 3 Yr 5 Yr 10 Yr Inception Polen Emerging Markets...
News
As a financial coach and consultant, I provide education around the intersection of money and mental health from the position of an expert. My...
News
In the dynamic world of pharmaceuticals, Merck & Co., Inc. (NYSE:MRK) has consistently emerged as a formidable player, showcasing resilience and innovation. While recent...
News
Introduction Regeneron Pharmaceuticals (NASDAQ:REGN) is a leading biotech firm that invents, develops, manufactures, and sells medicines for serious illnesses, including eye diseases, allergies, cancer,...
